» Articles » PMID: 36580261

L-2-Hydroxyglutaric Acid Administration to Neonatal Rats Elicits Marked Neurochemical Alterations and Long-Term Neurobehavioral Disabilities Mediated by Oxidative Stress

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2022 Dec 29
PMID 36580261
Authors
Affiliations
Soon will be listed here.
Abstract

L-2-Hydroxyglutaric aciduria (L-2-HGA) is an inherited neurometabolic disorder caused by deficient activity of L-2-hydroxyglutarate dehydrogenase. L-2-Hydroxyglutaric acid (L-2-HG) accumulation in the brain and biological fluids is the biochemical hallmark of this disease. Patients present exclusively neurological symptoms and brain abnormalities, particularly in the cerebral cortex, basal ganglia, and cerebellum. Since the pathogenesis of this disorder is still poorly established, we investigated the short-lived effects of an intracerebroventricular injection of L-2-HG to neonatal rats on redox homeostasis in the cerebellum, which is mostly affected in this disorder. We also determined immunohistochemical landmarks of neuronal viability (NeuN), astrogliosis (S100B and GFAP), microglia activation (Iba1), and myelination (MBP and CNPase) in the cerebral cortex and striatum following L-2-HG administration. Finally, the neuromotor development and cognitive abilities were examined. L-2-HG elicited oxidative stress in the cerebellum 6 h after its injection, which was verified by increased reactive oxygen species production, lipid oxidative damage, and altered antioxidant defenses (decreased concentrations of reduced glutathione and increased glutathione peroxidase and superoxide dismutase activities). L-2-HG also decreased the content of NeuN, MBP, and CNPase, and increased S100B, GFAP, and Iba1 in the cerebral cortex and striatum at postnatal days 15 and 75, implying long-standing neuronal loss, demyelination, astrocyte reactivity, and increased inflammatory response, respectively. Finally, L-2-HG administration caused a delay in neuromotor development and a deficit of cognition in adult animals. Importantly, the antioxidant melatonin prevented L-2-HG-induced deleterious neurochemical, immunohistochemical, and behavioral effects, indicating that oxidative stress may be central to the pathogenesis of brain damage in L-2-HGA.

Citing Articles

3-Hydroxy-3-Methylglutaric Acid Disrupts Brain Bioenergetics, Redox Homeostasis, and Mitochondrial Dynamics and Affects Neurodevelopment in Neonatal Wistar Rats.

de Andrade Silveira J, Marcuzzo M, da Rosa J, Kist N, Hoffmann C, Carvalho A Biomedicines. 2024; 12(7).

PMID: 39062136 PMC: 11274636. DOI: 10.3390/biomedicines12071563.

References
1.
Anghileri E, Bertolino N, Salsano E, Antelmi L, Carpinelli P, Castellotti B . In-vivo brain H1-MR-Spectroscopy identification and quantification of 2-hydroxyglutarate in L-2-Hydroxyglutaric aciduria. Brain Res. 2016; 1648(Pt A):506-511. DOI: 10.1016/j.brainres.2016.08.013. View

2.
Arakawa H, Erzurumlu R . Role of whiskers in sensorimotor development of C57BL/6 mice. Behav Brain Res. 2015; 287:146-55. PMC: 4430837. DOI: 10.1016/j.bbr.2015.03.040. View

3.
Aridas J, Yawno T, Sutherland A, Nitsos I, Ditchfield M, Wong F . Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs. J Pineal Res. 2018; 64(4):e12479. PMC: 5947141. DOI: 10.1111/jpi.12479. View

4.
Ayala A, Munoz M, Arguelles S . Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014; 2014:360438. PMC: 4066722. DOI: 10.1155/2014/360438. View

5.
Barth P, Hoffmann G, Jaeken J, Lehnert W, Hanefeld F, van Gennip A . L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol. 1992; 32(1):66-71. DOI: 10.1002/ana.410320111. View